Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02528097 · ClinicalTrials.gov registry record · NA
A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02528097 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 2 participants.
The verdict
NCT02528097, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Spontaneous bacterial peritonitis (SBP) is a common and frequently fatal complication of end-stage liver disease with a mortality of up to 10% primarily due to the development of kidney failure. Current standard practice is to treat this infection with broad spectrum antibiotics and salt-poor albumin administration on day one and three of treatment. In this study the investigators test the hypothesis that the administration of a second dose of albumin at 48 hours only to patients with renal insufficiency is as effective at preventing kidney failure as administering the second dose to all patients at 72 hours. In addition, a kidney function determined approach to albumin dosing may lead to substantial cost and resource saving from decreased albumin use without compromising treatment efficacy.
Interventions
- DRUG Standard Care
- DRUG Experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-09 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02528097
The ClinicalTrials.gov registry entry for NCT02528097 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02528097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02528097 about?
NCT02528097 is a clinical study titled "A Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis". Spontaneous bacterial peritonitis (SBP) is a common and frequently fatal complication of end-stage liver disease with a mortality of up to 10% primarily due to the development of kidney failure. Current standard practice is to treat this infection with broad spectrum antibiotics and salt-poor albumi...
What is the current status of trial NCT02528097?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2010-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02528097?
The interventions under investigation include: Standard Care (DRUG), Experimental (DRUG).
Who is sponsoring clinical trial NCT02528097?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.